Welcome to LookChem.com Sign In|Join Free

CAS

  • or

102976-58-9

Post Buying Request

102976-58-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

102976-58-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 102976-58-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,2,9,7 and 6 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 102976-58:
(8*1)+(7*0)+(6*2)+(5*9)+(4*7)+(3*6)+(2*5)+(1*8)=129
129 % 10 = 9
So 102976-58-9 is a valid CAS Registry Number.

102976-58-9Relevant articles and documents

Isomer-selective and enantiomerselective determination of DDT and related compounds using chiral high-resolution gas chromatography/mass spectrometry and chiral high-performance liquid chromatography

Buser, Hans-Rudolf,Mueller, Markus D.

, p. 2691 - 2698 (1995)

The composition of technical DDT was investigated using achiral and chiral high-resolution gas chromatography (HRGC) and electron-ionization mass spectrometry (EIMS). 2,4′-DDT and 2,4′-DDD, two important components of technical DDT, were enantiomerically resolved by chiral HRGC with silylated β-cyclodextrin and by chiral high-performance chromatography (HPLC) with permethylated γ-cyclodextrin as chiral selectors. The (+)- and (-)- enantiomers were assigned by chiral HPLC using chiroptical measurements. Enantiopure isolates were then used to identify these enantiomers in chiral HRGC analyses. Previous data indicated (+)- and (-)-2,4′-DDT to have S- and R-configuration, respectively, but the absolute configurations for (+)- and (-)-2,4′-DDD were hitherto unknown. They were now assigned via the reductive dechlorination of the individual 2,4′-DDT enantiomers which proceeded stereoselectively to the corresponding 2,4′-DDD enantiomers. The results showed (+)- and (-)-2,4′-DDD to have R- and S-configuration, respectively. The enantiomers of 2,4′-DDD thus have reversed signs of rotation for polarized light compared to the enantiomers of 2,4′-DDT with the same configuration. The enantiomer resolution of several additional chiral compounds in technical DDT is reported; enantiomeric ratios of ≈1.0 indicated all chiral compounds to be present as racemates in the technical and in the synthetic reference materials. We report the first enantioselective determinations of technical DDT; the methods presented should also be applicable to the analysis of environmental and biological samples.

Visible-light-promoted oxidative halogenation of alkynes

Li, Yiming,Mou, Tao,Lu, Lingling,Jiang, Xuefeng

, p. 14299 - 14302 (2019)

In nature, halogenation promotes the biological activity of secondary metabolites, especially geminal dihalogenation. Related natural molecules have been studied for decades. In recent years, their diversified vital activities have been explored for treating various diseases, which call for efficient and divergent synthetic strategies to facilitate drug discovery. Here we report a catalyst-free oxidative halogenation achieved under ambient conditions (halide ion, air, water, visible light, room temperature, and normal pressure). Constitutionally, electron transfer between the oxygen and halide ion is shuttled via simple conjugated molecules, in which phenylacetylene works as both reactant and catalyst. Synthetically, it provides a highly compatible late-stage transformation strategy to build up dihaloacetophenones (DHAPs).

Anti-Claudin 3 Monoclonal Antibody and Treatment and Diagnosis of Cancer Using the Same

-

, (2010/05/13)

Monoclonal antibodies that bind specifically to Claudin 3 expressed on cell surface are provided. The antibodies of the present invention are useful for diagnosis of cancers that have enhanced expression of Claudin 3, such as ovarian cancer, prostate cancer, breast cancer, uterine cancer, liver cancer, lung cancer, pancreatic cancer, stomach cancer, bladder cancer, and colon cancer. The present invention provides monoclonal antibodies showing cytotoxic effects against cells of these cancers. Methods for inducing cell injury in Claudin 3-expressing cells and methods for suppressing proliferation of Claudin 3-expressing cells by contacting Claudin 3-expressing cells with a Claudin 3-binding antibody are disclosed. The present application also discloses methods for diagnosis or treatment of cancers.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 102976-58-9